Seneca Biopharma Current Cash

Seneca Biopharma (SNCA) currently reports a current cash of $11M as of December 2020. That compares with $5.1M in the prior-year period — up 105.9% year over year. Use the charts on this page to explore Seneca Biopharma's current cash history and peer comparisons.

Seneca Biopharma's current cash increased from $5.1M to $11M — a 105.9% year-over-year increase (period ending December 2020). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Seneca Biopharma reported $11M in current cash as of December 2020. That compares with $5.1M in the prior-year period — up 105.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Seneca Biopharma, and consider following SNCA for alerts when major investors trade the stock.

Seneca Biopharma is classified in the Healthcare sector. On current cash, it currently shows $11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing SNCA with unrelated industries.